Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sibannac is a U.S.-based publicly traded wellness holding company that develops, markets, and supports alternative wellness, nutraceutical, and consumer packaged products. The company has evolved from cannabis and supplement manufacturing into a broader portfolio model centered on direct-to-consumer wellness brands, functional foods, media, and experiential offerings. Its current business emphasizes brand incubation and operational support through The Campus Co platform, with subsidiaries and brands including NOHO, Cherryology, RaD8 Life, Higher Times, Starwalker Cafe, and related consciousness-oriented ventures. Although sometimes categorized under healthcare or pharmaceutical industry codes, Sibannac does not appear to operate as a traditional biotech or drug-development company with a clinical-stage therapeutic pipeline. Instead, it is better understood as a commercial-stage alternative wellness and consumer health company with public-market exposure through the OTC market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sibannac.